PHARMACOGENETICS OF INTRAVENOUS AND ORAL BUSULFAN IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

Kinetics-based dose targeting is often conducted in hematopoietic cell transplant (HCT) patients conditioned with intravenous (IV) or oral busulfan to lower rates of rejection, nonrelapse mortality, and relapse. Using the candidate gene approach, we evaluated whether busulfan clearance was associate...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Abbasi, Nissa, Vadnais, Barbara, Knutson, Jennifer A., Blough, David K., Kelly, Edward J., O’Donnell, Paul V., Deeg, H. Joachim, Pawlikowski, Matthew, Ho, Rodney J. Y., McCune, Jeannine S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117932/
https://ncbi.nlm.nih.gov/pubmed/21135089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270010382915
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller